Volume share of generic pharmaceuticals in Estonia 2010-2022

In 2022, the share of generics in respective pharmaceutical market in Estonia decreased by 1.1 percent of sales volume in the same market (-2.88 percent) since 2021. Nevertheless, the last two years recorded a significant higher share than the preceding years.Find more key insights for the share of generics in respective pharmaceutical market in countries like France, Czechia, and Portugal.

在2022年，爱沙尼亚相应药品市场的仿制药份额较2021年同期下降了1.1%，降幅为该市场销售总量的2.88%。尽管如此，过去两年录得的份额显著高于前几年。欲了解更多关于法国、捷克共和国和葡萄牙等国家相应药品市场仿制药份额的关键洞察。